UPDATE 1-Sanofi exploring bid for Actelion amid J&J talks - Bloomberg

Dec 5 (Reuters) - Sanofi is considering a bid for Swiss biotech company Actelion, rivaling an offer made by U.S. healthcare company Johnson & Johnson, Bloomberg reported.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.